Showing results (101-110 of 220) with videos related to
Sort By:
Pageof 22
Disease Markers|April 12, 2016
CD38 Expression in a Subset of Memory T Cells Is Independent of Cell Cycling as a Correlate of HIV Disease ProgressionDaniela Würsch, Christopher E Ormsby, Dámaris P Romero-Rodríguez, et al.Frontiers in Aging|January 5, 2026
CD38 promotes LPS-induced innate-like activation and proliferation of CD8+ T lymphocytes in aged miceWendolaine Santiago-Cruz, Enrique Espinosa, Jocelyn C Pérez-Lara, et al.Journal of Cancer Survivorship : Research and Practice|November 24, 2020
Cancer survivors referred to a long-term survivorship outpatient service within academic medical oncology: descriptive studyAlejandro Gallego, Beatriz Martínez, Ismael Ghanem, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 28, 2023
Different outcomes among patients with intermediate-risk metastastic renal cell carcinoma treated with first-line tyrosine-kinase inhibitorsÁlvaro Pinto, Jesús Miranda, Ana Pertejo, et al.Dalton Transactions (Cambridge, England : 2003)|December 12, 2013
Inter-layer charge disproportionation in the dual-layer organic metal (tTTF-I)2ClO4 with unsymmetrical I···O halogen bond interactionsKyoung-Soon Shin, Olivier Jeannin, Mariya Brezgunova, et al.Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|February 18, 2022
Cardiac monitoring during trastuzumab therapy in metastatic breast cancer: early incidence of cardiac dysfunctionFrancesco Perone, Pilar Zamora Auñon, Laura Rodríguez, et al.Cell & Bioscience|May 3, 2023
Impacts of plasma microbial lipopolysaccharide translocation on B cell perturbations and anti-CD4 autoantibody production in people with HIV on suppressive antiretroviral therapyXiaoyu Fu, Da Cheng, Zhenwu Luo, et al.American Journal of Therapeutics|November 2, 2013
Who benefits most from adjuvant interferon treatment for melanoma?Helen Gogas, Huseyin Abali, Paolo A Ascierto, et al.Clinical Breast Cancer|July 2, 2017
Single-Agent Oral Vinorelbine as First-Line Chemotherapy for Endocrine-Pretreated Breast Cancer With Bone Metastases and No Visceral Involvement: NORBREAST-228 Phase II StudyGuenther G Steger, Adriana Dominguez, Natalia Dobrovolskaya, et al.Advances in Therapy|August 23, 2014
Melanoma: diagnosis, staging, and treatment. Consensus group recommendationsAlfonso Berrocal, Luis Cabañas, Enrique Espinosa, et al.Pageof 22